Meet our prostate cancer blogger Patrick. He's had first hand experience of the condition, and speaks to us candidly about his fight.
ITV has teamed up with charity Prostate Cancer UK to ask people to stand by the men in their lives and fight against the disease.
Actor Neil Stuke, who stars alongside Ray Winstone and Tamzin Outhwaite in a new film about prostate cancer, writes about the disease.
Today marks the launch of a new short film starring Ray Winstone and Tamzin Outhwaite about prostate cancer.
Father's Day - which also stars Charles Dance, John Simm and Neil Stuke - will screen on this Sunday on ITV4. Watch the trailer below.
Scientists have identified a gene that could be instrumental in the growth of prostate tumours.
The discovery could lead to improved cancer diagnosis and treatment, according to researchers from the University of Edinburgh.
They looked at genes which control how the prostate gland is formed and found that one gene, called decorin, may have a key role in tumour growth.
– Lead researcher Dr Axel Thomson, from the university's Medical Research Centre for Reproductive Health
We pinpointed which genes were active in embryonic prostate development and compared their behaviour in the development of prostate cancer.
Through this process we were excited to discover that the presence of one gene, decorin, was reduced in tumours compared to normal prostate cells.
This observation suggests that decorin's normal role may be to slow cancer growth, which is a really exciting possibility.
– Dr Kate Holmes, head of research at The Prostate Cancer Charity
"Early data from the PIVOT trial certainly suggests that surgery to remove the prostate does not provide any significant survival benefit for men with low to medium risk prostate cancer.
"However, these findings are from a large ongoing trial, and we look forward to seeing the full published results which could help men in future to make more informed decisions about treatment. "
New research on prostate cancer will challenge the way the disease is treated, reports the Independent.
The results of the Prostate Intervention Versus Observation Trial (PIVOT), which began in 1994 with 731 men, show a negligible difference between patients that had standard surgical treatment and those who had none.
The study compared surgical removal of the prostate gland with "watchful waiting" (doing nothing).
Standard methods for treating prostate cancer are ineffective and do not extend life, according to the world's biggest randomised trial of the disease.
The results of the 18-year study would "shake" cancer experts, says a report in today's Independent.
Cancer of the prostate is the commonest male cancer affecting 37,000 men a year in the UK and causing 10,000 deaths.